Scouring 12+ silos delayed critical IP checks. GenAI unified search, letting 4 analysts match the output of a 100-person team.
The world's largest investor in biopharmaceutical royalties evaluates over 400 opportunities annually while managing more than 100 terabytes of complex claims data.
Analysts struggled to manually scour over a dozen disconnected data sources to assess risks, leaving critical tasks like IP monitoring consistently...
“Before AlphaSense, our analysts spent hours scanning hundreds of industry journals just to find that nugget of information that might make or break an investment thesis. Now, with AlphaSense surfacing the most relevant information instantly, we can make informed decisions in a fraction of the time, cutting out tedious manual research and significantly reducing investment risk.”
Buyer of biopharmaceutical royalties and funder of life sciences innovation.
AI-powered market intelligence and search platform for business professionals.
Related implementations across industries and use cases
Analysts spent 4 days stitching fragmented insights. GenAI now synthesizes internal and market data, cutting deep dives to half a day.
Associates spent hours manually synthesizing broker reports. A vertical LLM now generates instant summaries grounded in public data.
Bankers spent hours manually reviewing files. AI agents now scan 50M documents to generate presentation-ready analysis instantly.
Advisors hunted data across five systems. GenAI now builds traceable meeting packs, saving 4,700 hours a year.
35M customers waited in queues for payment updates. Now, a voice agent resolves routine calls instantly, leaving complex issues to humans.
Rigid queries across scattered systems missed intel. Natural language search now captures synonyms and unifies sources automatically.
Scattered manual research slowed high-stakes answers. GenAI now cuts analysis from weeks to minutes for 13,000 employees.